Literature DB >> 7620977

Increased reliability of selective PCR by using additionally mutated primers and a commercial Taq DNA polymerase enhancer.

A De Milito1, M Catucci, F Iannelli, L Romano, M Zazzi, P E Valensin.   

Abstract

A reliable selective PCR procedure that combines the use of additionally mutated primers with the specificity-enhancing properties of a commercial preparation (Perfect Match, Stratagene) is described. The human immunodeficiency virus type 1 pol gene point mutations known to confer in vitro resistance to azidothymidine were examined as a model for optimization of the assay. The usual strategy of deliberately introducing an additional mismatch 1 residue from the 3' end in the wild-type and mutant primers did not allow reproducible discrimination between wild-type and mutant target sequences. Addition of minimal amounts of Perfect Match to the same PCR mixtures resulted in a significantly enlarged range of selective annealing temperatures, providing a valuable and cost-effective means for reliable detection of known mutations by selective PCR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7620977     DOI: 10.1007/BF02789112

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  9 in total

1.  A rapid PCR method of screening for small mutations.

Authors:  J G Major
Journal:  Biotechniques       Date:  1992-01       Impact factor: 1.993

2.  A replication-deficient HIV-1 DNA used for quantitation of the polymerase chain reaction (PCR).

Authors:  C Hart; S Y Chang; S Kwok; J Sninsky; C Y Ou; G Schochetman
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

3.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).

Authors:  C R Newton; A Graham; L E Heptinstall; S J Powell; C Summers; N Kalsheker; J C Smith; A F Markham
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

4.  Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).

Authors:  B A Larder; S D Kemp
Journal:  Science       Date:  1989-12-01       Impact factor: 47.728

5.  Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies.

Authors:  S Kwok; D E Kellogg; N McKinney; D Spasic; L Goda; C Levenson; J J Sninsky
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

6.  Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes.

Authors:  B A Larder; P Kellam; S D Kemp
Journal:  AIDS       Date:  1991-02       Impact factor: 4.177

7.  Low human immunodeficiency virus type 1 (HIV-1) DNA burden as a major cause for failure to detect HIV-1 DNA in clinical specimens by PCR.

Authors:  M Zazzi; L Romano; M Catucci; A De Milito; P Almi; A Gonnelli; M Rubino; P E Valensin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

8.  Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine.

Authors:  P Kellam; C A Boucher; B A Larder
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Simultaneous amplification of multiple HIV-1 DNA sequences from clinical specimens by using nested-primer polymerase chain reaction.

Authors:  M Zazzi; L Romano; A Brasini; P E Valensin
Journal:  AIDS Res Hum Retroviruses       Date:  1993-04       Impact factor: 2.205

  9 in total
  1 in total

1.  Detection of YMDD mutation using mutant-specific primers in chronic hepatitis B patients before and after lamivudine treatment.

Authors:  Cha-Ze Lee; Hsuan-Shu Lee; Guan-Tarn Huang; Pei-Ming Yang; Jin-Chuan Sheu
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.